Genetics of Psychiatric Disorders

On this page

Genetics of Psychiatric Disorders - Genes & Minds

  • Heritability ($H^2 = V_G / V_P$): Genetic contribution to trait variance.

    • High: Schizophrenia ~80%; Bipolar ~70-80%; ADHD ~75%; ASD ~70-90%.
  • Inheritance:

    TypeGenesEffectRelevance in Psychiatry
    MonogenicSingleLargeRare
    PolygenicMultipleSmall, additiveCommon (most disorders)
  • Gene-Environment Interaction (GxE): Diathesis-stress model (genes + stress → disorder).

  • Epigenetics: Altered gene expression, not DNA sequence (DNA methylation, histone modification).

    • 📌 Epi: Methylates Histones (Epigenetics: Methylation, Histone modification).
  • ⭐ > Twin studies (MZ vs. DZ) are crucial for estimating heritability of psychiatric disorders.

Genetics of Psychiatric Disorders - Unraveling Roots

Psychiatric disorders have a significant genetic basis, influenced by multiple genes and environmental interactions.

  • High Heritability: Many disorders show strong familial aggregation and high heritability estimates.
  • Polygenic Risk: Most disorders arise from the combined effects of many common variants (Single Nucleotide Polymorphisms - SNPs), each with a small effect.
  • Rare Variants: Copy Number Variations (CNVs) (e.g., 22q11.2 deletion) can confer substantial risk, especially for neurodevelopmental disorders.

Key Psychiatric Disorders: Genetic Insights

DisorderHeritability Est.Example Genes/LociPredominant Variants
Schizophrenia~80%DISC1, CACNA1C, 22q11.2 deletionSNPs, CNVs
Bipolar Disorder~75-80%CACNA1C, ANK3, TRANK1SNPs, CNVs
MDD~30-40%SLC6A4 (SERT), 5-HTTLPRSNPs
Autism Spectrum (ASD)>80%SHANK3, NRXN1, 15q11-q13 dup, 16p11.2 delCNVs, SNPs, mutations
ADHD~75%DAT1 (SLC6A3), DRD4, SNAP25SNPs

Chromosome 22q11.2 deletion

⭐ > Copy Number Variations (CNVs) are increasingly recognized as important risk factors for neurodevelopmental disorders like ASD and schizophrenia, often conferring higher risk than common SNPs.

Genetics of Psychiatric Disorders - Tailored Treatments

Pharmacogenomics: Genetic variations influence drug response, guiding personalized psychiatric treatments.

  • Pharmacokinetics (PK):
    • Key CYP enzymes (CYP2D6, CYP2C19, CYP2C9, CYP1A2) metabolize psychotropics (SSRIs, TCAs, antipsychotics).
    • Metabolizer phenotypes (Poor, Intermediate, Extensive, Ultra-rapid) impact drug levels, efficacy, and side effects.
      EnzymeCommon Psychotropic SubstratesClinical Implications of Polymorphisms (e.g., Poor Metabolizers)
      CYP2D6TCAs, fluoxetine, paroxetine, risperidone, aripiprazole↑ drug levels, ↑ side effects
      CYP2C19Citalopram, escitalopram, sertraline, TCAs, diazepam↑ drug levels, ↑ side effects (PMs); ↓ efficacy (UMs for active drugs)
      CYP2C9Valproate (minor), phenytoin↑ drug levels, ↑ toxicity
      CYP1A2Clozapine, olanzapine, duloxetine↑ drug levels (PMs); ↓ levels with inducers (e.g., smoking)
  • Pharmacodynamics (PD):
    • Genetic variations in drug targets (e.g., HTR2A receptors, SLC6A4 transporters) also affect treatment outcomes.
  • Specific Examples:
    • HLA-B*1502 allele: ↑ risk of carbamazepine-induced SJS.
    • HLA variants (e.g., HLA-DQB1): Linked to clozapine agranulocytosis & response.

⭐ Individuals who are CYP2D6 poor metabolizers may experience increased side effects or toxicity from standard doses of many antidepressants and antipsychotics.

Factors influencing individual drug response

Genetics of Psychiatric Disorders - Syndrome Spotlights

  • Down Syndrome: Trisomy 21; Psychiatric: Alzheimer's (early onset), depression.
  • Fragile X Syndrome: FMR1 gene mutation; Psychiatric: ASD, anxiety, ADHD.
  • Velocardiofacial Syndrome (22q11.2 Deletion): 22q11.2 deletion; Psychiatric: High psychosis risk (schizophrenia), anxiety.
  • Prader-Willi Syndrome: Paternal 15q11-q13 del/UPD; Psychiatric: Behavioral issues, hyperphagia, mood disorders.
  • Angelman Syndrome: Maternal 15q11-q13 del/UPD; Psychiatric: Severe developmental delay, happy demeanor, sleep issues.

Velocardiofacial syndrome (22q11.2 deletion) is one of the strongest known genetic risk factors for schizophrenia, with up to 30% of affected individuals developing psychosis.

High‑Yield Points - ⚡ Biggest Takeaways

  • Most psychiatric disorders follow polygenic inheritance, not Mendelian patterns.
  • High heritability seen in schizophrenia (~80%), bipolar disorder (~75%), and autism spectrum disorder.
  • Specific genes (e.g., COMT, BDNF, 5-HTTLPR) contribute, but with small individual effects.
  • Gene-environment interactions (GxE) are critical for disease development.
  • Epigenetic modifications, like DNA methylation, regulate gene expression.
  • Copy Number Variations (CNVs) are significant risk factors for several disorders.
  • Twin studies (higher MZ vs DZ concordance) strongly support genetic contributions.

Practice Questions: Genetics of Psychiatric Disorders

Test your understanding with these related questions

Which of the following is a polygenic disorder?

1 of 5

Flashcards: Genetics of Psychiatric Disorders

1/9

_____ theory assumes three sets of receptor systems, each of which functions as an antagonistic pair

TAP TO REVEAL ANSWER

_____ theory assumes three sets of receptor systems, each of which functions as an antagonistic pair

Opponent process

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial
Genetics of Psychiatric Disorders - Free Indian Medical PG